SG RNA tech firm completes $390m Series D funding; applies for HKEX

Mirxes creates diagnostic solutions to early detect diseases.

Singapore-headquartered Mirxes Holding Company Limited secured $390m (US$50m) Series D funding.

It will play a pivotal role in speeding up Mirxes’ delivery of cancer early-detection blood tests and preventive healthcare solutions in major markets.

The funding was supported by investors including Beijing Fupu, which the Management Committee of Zhejiang Anji Economic Development Zone indirectly owned a majority stake in, EDB Investments Pte Ltd, wholly owned by the Singapore Economic Development Board, Agency for Science, Technology, and Research, Singapore’s lead public sector R&D agency for scientific discovery and technological innovation, Mitsui & Co., Ltd., a company listed on various stock exchanges in Japan, and NHH Venture Fund.

The fresh investment will be used to scale the adoption and penetration of Mirxes’s flagship stomach cancer blood test, GASTROClearTM, in major Asia-Pacific markets including Southeast Asia, the People’s Republic of China (PRC), and Japan.

Aside from the funding, Mirxes said it lodged a listing application with The Stock Exchange of Hong Kong Limited (HKEX) under Chapter 18A of the Rules Governing the Listing of Securities on HKEX.

“The company's commitment to being a leading RNA-centric multi-omics technology company that provides accurate, accessible, and actionable diagnostic solutions to address critical unmet clinical needs across the care continuum has propelled it towards these milestones, which will provide enhanced opportunities for investors and further bolster Mirxes's global position,” read the statement.

This new investment will support Mirxes in its position to become a frontrunner in the fight against cancer through early detection.

“This fresh funding will fuel our ambitious growth plans and enable us to continue making a significant impact in the field of multi-cancer early detection,” said Mirxes CEO ZHOU Lihan.

$1 = US$0.13

Follow the link for more news on

startups

Also Read

HK records 35,373 new cancer cases in 2022

Braillic’s AR tech helps brain surgeons see through the walls

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit